4.8 Article

Skp2 Deletion Unmasks a p27 Safeguard that Blocks Tumorigenesis in the Absence of pRb and p53 Tumor Suppressors

Journal

CANCER CELL
Volume 24, Issue 5, Pages 645-659

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2013.09.021

Keywords

-

Funding

  1. National Institutes of Health [R01 CA127901, R01 CA131421]
  2. Albert Einstein Comprehensive Cancer Research Center [5P30CA13330]
  3. Albert Einstein Comprehensive Liver Research Center [5P30DK061153]
  4. U.S. Department of Defense Prostate Cancer Research Program Postdoctoral Fellowship [PC121837]
  5. Irma T. Hirschl Career Scientist Award
  6. Grants-in-Aid for Scientific Research [22130001, 22130003] Funding Source: KAKEN

Ask authors/readers for more resources

pRb and p53 are two major tumor suppressors. Here, we found that p53 activates expression of Pirh2 and KPC1, two of the three ubiquitin ligases for p27. Loss of p53 in the absence of Skp2, the third ubiquitin ligase for p27, shrinks the cellular pool of p27 ubiquitin ligases to accumulate p27 protein. In the absence of pRb and p53, p27 was unable to inhibit DNA synthesis in spite of its abundance, but could inhibit division of cells that maintain DNA replication with rereplication. This mechanism blocked pRb/p53 doubly deficient pituitary and prostate tumorigenesis lastingly coexistent with bromodeoxyuridine-labeling neoplastic lesions, revealing an unconventional cancer cell vulnerability when pRb and p53 are inactivated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available